Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Rhodes Jason P
Director at Dyne Therapeutics · Director at Replimune. Filing since 18 Nov 2019.
CIK 0001577014
DYN
Dyne Therapeutics, Inc.
Director · 31 trades
REPL
Replimune Group, Inc.
Director · 12 trades
Company
Date
Role
Action
Shares
Amount
Of holding
DYN
Dyne Therapeutics, Inc.
14 Aug 2026
Director
Sold on a plan
2,160,516
$54.01M
83.4%
DYN
Dyne Therapeutics, Inc.
13 Aug 2026
Director
Sold on a plan
426,412
$11.17M
36.2%
DYN
Dyne Therapeutics, Inc.
7 Jul 2026
Director
Sold on a plan
297,211
$6.91M
99.0%
DYN
Dyne Therapeutics, Inc.
6 Jul 2026
Director
Sold on a plan
480,240
$10.94M
35.4%
DYN
Dyne Therapeutics, Inc.
29 Jun 2026
Director
Sold on a plan
195,427
$4.13M
16.7%
DYN
Dyne Therapeutics, Inc.
26 Jun 2026
Director
Sold on a plan
309,268
$6.58M
23.3%
DYN
Dyne Therapeutics, Inc.
25 Jun 2026
Director
Sold on a plan
24,100
$508.51K
2.2%
DYN
Dyne Therapeutics, Inc.
24 Jun 2026
Director
Sold on a plan
95,900
$2.02M
8.1%
DYN
Dyne Therapeutics, Inc.
23 Jun 2026
Director
Sold on a plan
147,760
$3.12M
11.8%
DYN
Dyne Therapeutics, Inc.
6 May 2026
Director
Sold on a plan
83,219
$1.51M
91.3%
DYN
Dyne Therapeutics, Inc.
5 May 2026
Director
Sold on a plan
11,600
$209.15K
58.0%
DYN
Dyne Therapeutics, Inc.
4 May 2026
Director
Sold on a plan
11,904
$214.27K
58.5%
DYN
Dyne Therapeutics, Inc.
28 Apr 2026
Director
Sold on a plan
227,337
$4.18M
96.4%
DYN
Dyne Therapeutics, Inc.
27 Apr 2026
Director
Sold on a plan
173,493
$3.15M
94.7%
DYN
Dyne Therapeutics, Inc.
24 Apr 2026
Director
Sold on a plan
137,948
$2.55M
92.9%
DYN
Dyne Therapeutics, Inc.
23 Apr 2026
Director
Sold on a plan
73,108
$1.40M
86.6%
DYN
Dyne Therapeutics, Inc.
22 Apr 2026
Director
Sold on a plan
287,956
$5.67M
96.1%
DYN
Dyne Therapeutics, Inc.
21 Apr 2026
Director
Sold on a plan
274,297
$5.35M
95.4%
DYN
Dyne Therapeutics, Inc.
20 Apr 2026
Director
Sold on a plan
272,049
$5.46M
94.9%
DYN
Dyne Therapeutics, Inc.
14 Nov 2024
Director
Sold at will
782
$25.88K
4.7%
DYN
Dyne Therapeutics, Inc.
1 Mar 2024
Director
Sold on a plan
46,534
$1.40M
5.2%
DYN
Dyne Therapeutics, Inc.
28 Feb 2024
Director
Sold on a plan
190,920
$4.74M
18.1%
DYN
Dyne Therapeutics, Inc.
27 Feb 2024
Director
Sold on a plan
368,699
$9.00M
29.6%
DYN
Dyne Therapeutics, Inc.
26 Feb 2024
Director
Sold on a plan
248,219
$5.89M
21.6%
DYN
Dyne Therapeutics, Inc.
23 Feb 2024
Director
Sold on a plan
196,928
$4.47M
17.6%
DYN
Dyne Therapeutics, Inc.
22 Feb 2024
Director
Sold on a plan
119,360
$2.70M
1.8%
DYN
Dyne Therapeutics, Inc.
21 Feb 2024
Director
Sold on a plan
184,501
$4.16M
2.7%
DYN
Dyne Therapeutics, Inc.
20 Feb 2024
Director
Sold on a plan
169,539
$3.85M
2.4%
DYN
Dyne Therapeutics, Inc.
16 Feb 2024
Director
Sold on a plan
162,707
$3.77M
2.3%
DYN
Dyne Therapeutics, Inc.
15 Feb 2024
Director
Sold on a plan
177,906
$4.25M
2.4%
DYN
Dyne Therapeutics, Inc.
12 Dec 2022
Director
Bought
934,581
$10.00M
opened
REPL
Replimune Group, Inc.
26 Jan 2021
Director
Sold, plan not stated
5,558
$256.45K
0.6%
REPL
Replimune Group, Inc.
18 Dec 2020
Director
Sold, plan not stated
4,319
$181.18K
18.3%
REPL
Replimune Group, Inc.
17 Dec 2020
Director
Sold, plan not stated
11,535
$484.47K
37.1%
REPL
Replimune Group, Inc.
16 Dec 2020
Director
Sold, plan not stated
12,675
$534.00K
38.5%
REPL
Replimune Group, Inc.
15 Dec 2020
Director
Sold, plan not stated
40,819
$1.73M
66.0%
REPL
Replimune Group, Inc.
14 Dec 2020
Director
Sold, plan not stated
37,659
$1.64M
61.6%
REPL
Replimune Group, Inc.
11 Dec 2020
Director
Sold, plan not stated
31,636
$1.37M
55.1%
REPL
Replimune Group, Inc.
10 Dec 2020
Director
Sold, plan not stated
34,391
$1.48M
55.4%
REPL
Replimune Group, Inc.
9 Dec 2020
Director
Sold, plan not stated
41,216
$1.80M
58.1%
REPL
Replimune Group, Inc.
8 Dec 2020
Director
Sold, plan not stated
108,256
$5.06M
77.1%
REPL
Replimune Group, Inc.
7 Dec 2020
Director
Sold, plan not stated
67,890
$3.12M
65.5%
REPL
Replimune Group, Inc.
18 Nov 2019
Director
Bought
1,100,000
$14.97M
opened
43 decisions on file.
